Drug
quinacrine
quinacrine is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 23 (75.0%)
N/A1 (25.0%)
Trials by Status
withdrawn125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnphase_2
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
NCT00574483
completednot_applicable
PRION-1: Quinacrine for Human Prion Disease
NCT00104663
completedphase_2
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
NCT00183092
completedphase_2
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
NCT00417274
Clinical Trials (4)
Showing 4 of 4 trials
NCT00574483Phase 2
Treatment of Advanced Renal Cell Carcinoma With Quinacrine
NCT00104663Not Applicable
PRION-1: Quinacrine for Human Prion Disease
NCT00183092Phase 2
CJD (Creutzfeldt-Jakob Disease) Quinacrine Study
NCT00417274Phase 2
Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4